Marcaine 0.25% Inj, 50ml

Manufacturer HOSPIRA Active Ingredient Bupivacaine Injection(byoo PIV a kane) Pronunciation byoo-PIV-a-kane
WARNING: Seizures, sudden loss of heart function, and death have been reported when this drug was used as an epidural during childbirth. Most of the time, this happened with a certain strength of this drug that is not meant for use during labor. If you have questions, talk with the doctor. @ COMMON USES: It is used to numb an area before a procedure.
đŸˇī¸
Drug Class
Local Anesthetic
đŸ§Ŧ
Pharmacologic Class
Amide-type Local Anesthetic
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1972
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Bupivacaine is a medicine used to numb a part of your body. It works by temporarily blocking nerve signals, so you don't feel pain during a medical procedure or surgery. It's often used for local numbing, nerve blocks, or epidurals.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the instructions carefully. This medication is administered via injection.

Storing and Disposing of Your Medication

This medication will be administered in a hospital or doctor's office, so you will not need to store it at home.

Missing a Dose

Since this medication is given as needed in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication according to your medical needs.
💡

Lifestyle & Tips

  • Avoid eating or drinking until sensation returns to the treated area to prevent choking or biting your tongue/cheek.
  • Avoid activities requiring fine motor skills or full sensation (e.g., driving, operating machinery) until the effects of the anesthetic have completely worn off.
  • Protect the numb area from injury (e.g., burns, cuts) as you won't feel pain.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure, site, and patient. For 0.25% solution, typical doses range from 5 mg to 175 mg (2 mL to 70 mL). Max single dose generally 175 mg (70 mL of 0.25%) or 400 mg/24 hours.
Dose Range: 5 - 175 mg

Condition-Specific Dosing:

localInfiltration: Up to 70 mL of 0.25% (175 mg)
peripheralNerveBlock: 5-175 mg (2-70 mL of 0.25%) depending on nerve and site
epiduralBlock: 25-100 mg (10-40 mL of 0.25%) for surgical anesthesia; 12.5-25 mg (5-10 mL of 0.25%) for obstetric analgesia
caudalBlock: 37.5-75 mg (15-30 mL of 0.25%)
spinalBlock: Not typically used for spinal block at 0.25% concentration; hyperbaric solutions are used for spinal anesthesia.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; extreme caution if used. Max 2 mg/kg.
Infant: Max 2 mg/kg. Not recommended for children under 12 years for epidural block.
Child: Max 2 mg/kg. Not recommended for children under 12 years for epidural block. For caudal block, 1.25 mg/kg (0.5 mL/kg of 0.25%) up to 2.5 mg/kg (1 mL/kg of 0.25%).
Adolescent: Similar to adult dosing, but with careful weight-based calculation and lower maximums (e.g., 2 mg/kg up to 175 mg).
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended.
Moderate: No specific adjustment recommended.
Severe: No specific adjustment recommended, but monitor for systemic toxicity due to potential accumulation of metabolites. Use lowest effective dose.
Dialysis: Not significantly removed by hemodialysis. Use with caution, monitor for toxicity.

Hepatic Impairment:

Mild: No specific adjustment recommended.
Moderate: Use with caution. Consider reduced doses and monitor for systemic toxicity due to impaired metabolism.
Severe: Use with extreme caution. Significant dose reduction may be necessary. Monitor closely for systemic toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Bupivacaine is an amide-type local anesthetic. It reversibly blocks the initiation and conduction of nerve impulses by decreasing the permeability of the neuronal membrane to sodium ions. This action stabilizes the membrane and inhibits depolarization, preventing the propagation of the action potential.
📊

Pharmacokinetics

Absorption:

Bioavailability: Varies significantly based on site of administration (e.g., intercostal block > caudal > epidural > brachial plexus > subcutaneous). Systemic absorption occurs from the site of administration.
Tmax: Variable, typically 30-45 minutes after epidural administration, but depends on site and vascularity.
FoodEffect: Not applicable (parenteral administration).

Distribution:

Vd: Approximately 0.7-2.7 L/kg (adults)
ProteinBinding: Approximately 95% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (crosses blood-brain barrier, responsible for CNS effects/toxicity)

Elimination:

HalfLife: Approximately 1.5-5.5 hours (adults), longer in neonates and patients with hepatic impairment.
Clearance: Approximately 0.47 L/min (adults)
ExcretionRoute: Renal (primarily as metabolites, small amount as unchanged drug)
Unchanged: Approximately 5-10% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: 2-10 minutes (depending on concentration, dose, and site of injection)
PeakEffect: 30-45 minutes
DurationOfAction: 2-8 hours (dose and concentration dependent; longer than lidocaine)
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

There have been reports of cardiac arrest and death during the use of bupivacaine for epidural anesthesia in obstetrical patients. In most cases, this has followed accidental intravascular injection of bupivacaine. Therefore, 0.75% bupivacaine is not recommended for obstetrical epidural anesthesia. Resuscitative equipment and drugs, including lipid emulsion, should be immediately available when bupivacaine is administered.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Acidosis (Too Much Acid in the Blood): Confusion, fast breathing, fast heartbeat, irregular heartbeat, severe stomach pain, upset stomach, vomiting, excessive sleepiness, shortness of breath, or feeling extremely tired or weak.
Methemoglobinemia: Blue or gray discoloration of the lips, nails, or skin, irregular heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Cardiovascular Issues: Fast, slow, or abnormal heartbeat, chest pain or pressure, dizziness or fainting, lightheadedness, sleepiness, confusion, or blurred vision.
Neurological Symptoms: Change in balance, restlessness, anxiety, change in speech, shakiness, twitching, ringing in the ears, trouble breathing, slow breathing, or shallow breathing, seizures, numbness or tingling in the mouth, metallic taste.
Gastrointestinal Issues: Severe stomach upset or vomiting, feeling hot or cold, nervousness, excitability, sneezing, excessive sweating.
* Spinal-Related Symptoms: Difficulty urinating, loss of bladder or bowel control, erectile dysfunction, long-lasting burning, numbness, tingling, or paralysis in the lower half of the body, backache, fever or chills, stiff neck, sensitivity to bright lights.

Other Possible Side Effects

As with any medication, you may experience side effects. While many people do not experience any side effects or only minor ones, it is essential to contact your doctor if you have any symptoms that bother you or persist. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide guidance on managing side effects and offer medical advice.
🚨

Seek Immediate Medical Attention If You Experience:

  • Dizziness or lightheadedness
  • Ringing in the ears (tinnitus)
  • Metallic taste in the mouth
  • Numbness or tingling around the mouth or tongue
  • Blurred vision or double vision
  • Tremors or muscle twitching
  • Feeling unusually sleepy or confused
  • Difficulty breathing
  • Slow or irregular heartbeat
  • Feeling faint or dizzy when standing up
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Bleeding disorders
+ Abnormal heart rhythms
+ Blood infections or infections at the site where the medication will be administered
+ Low blood pressure
* If you are using or plan to use another medication similar to this one. If you are unsure, consult your doctor or pharmacist.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

General Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Until the effects of this drug have worn off and you feel fully alert, avoid driving and other activities that require your full attention.

Risk of Methemoglobinemia

This medication can cause a severe blood disorder called methemoglobinemia. Your risk may be higher if you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, heart problems, or lung problems. Additionally, the risk may increase when taking certain other medications or in infants under 6 months of age. If you have a history of methemoglobinemia, inform your doctor.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Not all products are suitable for children, so consult with your doctor before use. If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor to ensure the best outcome for you and your baby.

Mouth and Throat Precautions

When using this medication for mouth-related procedures, do not eat until the numbness has worn off, as you may accidentally bite your tongue.

Spinal Administration Precautions

After spinal administration of this medication, you may experience temporary loss of feeling and motor function in the lower half of your body. Wait until these effects have resolved before attempting to get out of bed or perform other activities.

Injection Precautions (Non-Spinal)

When this medication is administered via injection (other than spinal), you may experience temporary loss of feeling and motor function at the injection site.
🆘

Overdose Information

Overdose Symptoms:

  • Severe CNS depression (drowsiness, unconsciousness, respiratory arrest)
  • Seizures
  • Severe hypotension
  • Bradycardia
  • Ventricular arrhythmias (e.g., ventricular tachycardia, ventricular fibrillation)
  • Cardiac arrest

What to Do:

Immediate medical attention is required. Call 911 or emergency services. Treatment involves airway management, oxygenation, circulatory support, seizure control (e.g., benzodiazepines), and intravenous lipid emulsion therapy (Intralipid) for severe systemic toxicity. Call 1-800-222-1222 for Poison Control.

Drug Interactions

🔴

Major Interactions

  • Other local anesthetics (additive systemic toxicity)
  • Antiarrhythmics (e.g., Class I antiarrhythmics like mexiletine, lidocaine, tocainide - increased risk of cardiac depression/toxicity)
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir) - potential for increased bupivacaine levels and toxicity.
🟡

Moderate Interactions

  • Opioids (synergistic analgesic effect, but increased risk of respiratory depression when used intrathecally/epidurally)
  • Sedatives/Hypnotics (additive CNS depression)
  • Neuromuscular blockers (prolongation of block, though less common with bupivacaine)
  • Vasoconstrictors (e.g., epinephrine - prolongs duration of action, but also increases systemic absorption of bupivacaine if not used carefully)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history and physical exam

Rationale: Assess for contraindications, comorbidities (cardiac, hepatic, renal disease), and previous reactions to local anesthetics.

Timing: Pre-procedure

Vital signs (HR, BP, RR, SpO2)

Rationale: Establish baseline and detect early signs of systemic toxicity or adverse reactions.

Timing: Pre-procedure

Allergy history

Rationale: Identify potential hypersensitivity reactions.

Timing: Pre-procedure

📊

Routine Monitoring

Vital signs (HR, BP, RR, SpO2)

Frequency: Continuously during and immediately after injection, then regularly until recovery.

Target: Within patient's normal limits, stable.

Action Threshold: Significant deviations (e.g., bradycardia, hypotension, respiratory depression) require immediate intervention.

Level of consciousness/Neurological status

Frequency: Continuously during and immediately after injection, then regularly.

Target: Alert and oriented, no signs of CNS toxicity (e.g., dizziness, tinnitus, seizures).

Action Threshold: Signs of CNS toxicity (e.g., circumoral numbness, metallic taste, lightheadedness, visual disturbances, muscle twitching, seizures) require immediate intervention.

Sensory and motor block assessment

Frequency: As needed to confirm block efficacy and monitor regression.

Target: Appropriate level of anesthesia/analgesia for the procedure.

Action Threshold: Inadequate block or signs of high/total spinal block (if epidural/spinal).

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus
  • Metallic taste
  • Numbness of tongue/lips (circumoral numbness)
  • Visual disturbances (blurred vision, diplopia)
  • Tremors
  • Muscle twitching
  • Seizures
  • Drowsiness
  • Unconsciousness
  • Respiratory depression/arrest
  • Bradycardia
  • Hypotension
  • Cardiac arrhythmias
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Bupivacaine crosses the placenta. Fetal bradycardia and other adverse effects have been reported. The 0.75% concentration is contraindicated for obstetrical epidural anesthesia due to increased risk of cardiac arrest.

Trimester-Specific Risks:

First Trimester: Limited data, but generally avoided unless essential. Potential for fetal exposure.
Second Trimester: Generally considered safer than first trimester if needed, but still Category C.
Third Trimester: Commonly used for labor and delivery (epidural/spinal analgesia/anesthesia) at lower concentrations (e.g., 0.25% or less). Monitor maternal and fetal vital signs closely. Risk of fetal bradycardia.
🤱

Lactation

L2 (Safer). Bupivacaine is excreted into breast milk in small amounts. The amount ingested by the infant is very low and unlikely to cause adverse effects. Generally considered compatible with breastfeeding.

Infant Risk: Low risk. Monitor infant for unusual drowsiness or feeding difficulties, though unlikely.
đŸ‘ļ

Pediatric Use

Use with caution, especially in infants and young children, due to increased susceptibility to systemic toxicity and immature metabolic pathways. Dosing must be carefully calculated on a mg/kg basis, and maximum doses should not be exceeded. Not recommended for epidural block in children under 12 years due to higher risk of toxicity.

👴

Geriatric Use

Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced renal clearance of metabolites, and altered body composition. Consider lower doses and slower administration rates. Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Always aspirate before injection to avoid inadvertent intravascular administration, which can lead to severe systemic toxicity, including cardiac arrest.
  • Bupivacaine has a relatively long duration of action compared to other local anesthetics like lidocaine.
  • Cardiac toxicity is a major concern, especially with higher concentrations or accidental intravascular injection. Lipid emulsion (Intralipid) should be readily available for treatment of severe local anesthetic systemic toxicity (LAST).
  • The 0.75% concentration is contraindicated for obstetrical epidural anesthesia due to increased risk of cardiac arrest.
  • Onset of action is slower than lidocaine, but duration is longer.
  • Monitor for signs of CNS toxicity (e.g., circumoral numbness, tinnitus, lightheadedness, seizures) and cardiovascular toxicity (e.g., bradycardia, hypotension, arrhythmias).
🔄

Alternative Therapies

  • Lidocaine (shorter acting, less cardiotoxic)
  • Ropivacaine (similar to bupivacaine, but less cardiotoxic)
  • Levobupivacaine (S-enantiomer of bupivacaine, potentially less cardiotoxic)
  • Mepivacaine
  • Chloroprocaine (ester-type, very short acting)
💰

Cost & Coverage

Average Cost: Varies widely by supplier and volume (e.g., $10-$50 per 50mL vial of 0.25%) per 50mL vial
Generic Available: Yes
Insurance Coverage: Generally covered by most medical insurance plans as it is a standard hospital/clinic administered medication. Coverage tier is not applicable as it's not a retail prescription.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by a healthcare professional. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred.